Ra Capital Management as of Sept. 30, 2018
Portfolio Holdings for Ra Capital Management
Ra Capital Management holds 26 positions in its portfolio as reported in the September 2018 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Wave Life Sciences (WVE) | 20.1 | $376M | 7.5M | 50.00 | |
| Ascendis Pharma A S (ASND) | 16.1 | $301M | 4.2M | 70.86 | |
| Solid Biosciences | 6.8 | $127M | 2.7M | 47.18 | |
| Endocyte | 5.9 | $110M | 6.2M | 17.76 | |
| Zogenix | 5.0 | $93M | 1.9M | 49.60 | |
| Myovant Sciences | 4.9 | $92M | 3.5M | 26.55 | |
| BioCryst Pharmaceuticals (BCRX) | 3.8 | $71M | 9.2M | 7.63 | |
| Ra Pharmaceuticals | 3.7 | $70M | 3.9M | 18.09 | |
| Inflarx Nv (IFRX) | 3.6 | $68M | 2.0M | 34.32 | |
| Immunomedics | 3.5 | $65M | 3.1M | 20.83 | |
| Dicerna Pharmaceuticals | 3.2 | $60M | 3.9M | 15.26 | |
| Rhythm Pharmaceuticals (RYTM) | 3.0 | $57M | 2.0M | 29.17 | |
| Arvinas Ord (ARVN) | 2.8 | $53M | 3.1M | 16.87 | |
| Sage Therapeutics (SAGE) | 2.6 | $50M | 351k | 141.25 | |
| Crinetics Pharmaceuticals In (CRNX) | 2.6 | $49M | 1.7M | 28.65 | |
| Tg Therapeutics (TGTX) | 2.5 | $46M | 8.2M | 5.60 | |
| Momenta Pharmaceuticals | 2.2 | $41M | 1.6M | 26.30 | |
| Kalvista Pharmaceuticals (KALV) | 1.7 | $32M | 1.4M | 22.11 | |
| Eidos Therapeutics | 1.1 | $22M | 2.2M | 9.98 | |
| Kala Pharmaceuticals | 1.1 | $21M | 2.1M | 9.87 | |
| Progenics Pharmaceuticals | 1.0 | $19M | 3.0M | 6.27 | |
| Scpharmaceuticals (SCPH) | 0.9 | $17M | 2.9M | 5.87 | |
| Apellis Pharmaceuticals (APLS) | 0.9 | $16M | 900k | 17.78 | |
| Iovance Biotherapeutics (IOVA) | 0.7 | $13M | 1.1M | 11.25 | |
| Glycomimetics (GLYC) | 0.2 | $3.7M | 254k | 14.40 | |
| Proteon Therapeutics | 0.1 | $2.6M | 1.3M | 1.95 |
